Relevant bibliographies by topics / Anti-anginal/anti ischemic

Contents

  1. Journal articles
  2. Books
  3. Book chapters

Academic literature on the topic 'Anti-anginal/anti ischemic'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Anti-anginal/anti ischemic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Anti-anginal/anti ischemic"

1

Lardizabal, Joel A., and Prakash C. Deedwania. "The Anti-Ischemic and Anti-Anginal Properties of Statins." Current Atherosclerosis Reports 13, no. 1 (2010): 43–50. http://dx.doi.org/10.1007/s11883-010-0147-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wimmer, Neil J., and Peter H. Stone. "Anti-Anginal and Anti-Ischemic Effects of Late Sodium Current Inhibition." Cardiovascular Drugs and Therapy 27, no. 1 (2012): 69–77. http://dx.doi.org/10.1007/s10557-012-6431-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Малыгина, V. Malygina, Сергунина, et al. "Evaluation of effect of the coronater drug on the indices of deformation of the left ventricular myocardium in patients with chd." Journal of New Medical Technologies. eJournal 8, no. 1 (2014): 0. http://dx.doi.org/10.12737/7364.

Full text
Abstract:
Currently, the methods of early diagnosis and treatment of stable angina are of interest to researchers. One of the methods of diagnosis is echocardiography using a two-dimensional speckle tracking. Technology speckle tracking allows to evaluate systolic and diastolic heart function in various cardiovascular diseases, including coronary heart disease (CHD). By means of this program all types of myocardial deformation: radial, circular, longitudinal, the rate of deformation and rotation of the myocardium can be evaluated. The clinical studies have shown that changes in the indices of deformatio
APA, Harvard, Vancouver, ISO, and other styles
4

Abbas, Eslam, Ahmed Mahdy, and Shady Mansy. "Relentless Angina of a Scarred Heart." Cardiology and Cardiovascular Research 8, no. 4 (2024): 92–95. https://doi.org/10.11648/j.ccr.20240804.11.

Full text
Abstract:
Refractory anginal pain affects nearly 5-10% of stable coronary artery disease patients, and maximizing the anti-ischemic medical therapy is the standard first-line treatment. The presence of a scarred myocardial territory of the epicardial coronary chronic total occlusion (CTO) limits the implementation of other modalities, such as angioplasty and surgical bypass. Accordingly, this subset of patients, who show poor response to medical treatment with the absence of considerable reversible ischemia, bears an additional burden of persistent angina besides the structural and functional complicati
APA, Harvard, Vancouver, ISO, and other styles
5

A., H. M. Nazmul Hasan, Jahid Hasan Sk., Anzam Ul Islam Md., Awal Trina Afsana, Nahar Deepa Kanij, and Asaduzzaman Md. "Pattern of Pharmacotherapy of Patients Having Ischemic Heart Disease at a Specialized Hospital in Dhaka, Bangladesh: A Survey Based Study on Patients Discharged from Hospital." British Journal of Medicine & Medical Research 22, no. 2 (2017): 1–9. https://doi.org/10.9734/BJMMR/2017/34107.

Full text
Abstract:
<strong>Aims: </strong>Study on pharmacotherapeutic pattern on cardiovascular patients is rarely done. Patient’s demography, drug usage and its clinical outcome are the basis for the assessment of cardiac treatment. The aim of this study to analyze the demography of patients of ischemic heart disease along with drug usage and current trends of practice in Bangladesh. <strong>Methods: </strong>This study was carried out over a period of two months at different units of NICVD, situated at Dhaka, Bangladesh. A structured questionnaire was prepared to collect necessary data from patients. Descript
APA, Harvard, Vancouver, ISO, and other styles
6

Kobrin, Isaac, Gabriele Bieska, Vincent Charlon, Elisabet Lindberg, and Robert Pordy. "Anti-Anginal and Anti-Ischemic Effects of Mibefradil, a New T-Type Calcium Channel Antagonist." Cardiology 89, no. 1 (1998): 23–32. http://dx.doi.org/10.1159/000047276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zadionchenko, V. S., G. G. Shehyan, A. A. Yalymov, and S. I. Varentsov. "The use of ranolazine in the treatment of coronary heart disease." CardioSomatics 5, no. 3-4 (2014): 48–53. http://dx.doi.org/10.26442/cs45130.

Full text
Abstract:
The paper presents the study of a new anti-anginal drug - sodium channel inhibitor ranolazine. Considered antianginal, anti-ischemic effect of the drug. Described reduction in angina attacks, increased exercise tolerance and quality of life of patients with stable angina during treatment with ranolazine. Discusses indications, contraindications, side effects, as well as the major clinical trials of the drug ranolazine in patients with coronary heart disease.
APA, Harvard, Vancouver, ISO, and other styles
8

Tardif, Jean-Claude. "Safety and Efficacy of Ivabradine in the Management of Stable Angina Pectoris." Clinical Medicine. Therapeutics 1 (January 2009): CMT.S1086. http://dx.doi.org/10.4137/cmt.s1086.

Full text
Abstract:
The first selective If current inhibitor, ivabradine, lowers heart rate (HR) at rest and during exercise with no vasomotor, negative inotropic, or negative lusitropic effects. Given that elevated resting HR is a key factor in the onset of myocardial ischemia and a strong independent predictor of cardiovascular outcomes, ivabradine provides new therapeutic prospects in coronary artery disease (CAD). Its selective HR-lowering action has proven anti-ischemic and anti-anginal efficacy, and ivabradine is currently indicated for the symptomatic treatment of stable angina pectoris. Ivabradine can als
APA, Harvard, Vancouver, ISO, and other styles
9

S., Madhumitha V. Karan*. "Novel Drugs Approach in Treatment of Angina." International Journal of Scientific Research and Technology 2, no. 3 (2025): 477–82. https://doi.org/10.5281/zenodo.15085105.

Full text
Abstract:
Angina Pectoris is a common symptom of ischemic heart disease. In 1772 according to William Heberden Angina is characterized by the painful and disagreeable sensation that occurs in the breast during walking. This is caused as the result of the myocardial oxygen supply and demand imbalance.&nbsp; The oxygen demand increases due to tachycardia, hypertension, left ventricular hypertrophy.&nbsp; Tissue ischemia leads to series of metabolic changes which includes elevated intracellular lactate production and acidification that produces anginal symptoms.&nbsp; Besides coronary obstructive diseases,
APA, Harvard, Vancouver, ISO, and other styles
10

Sushil, Kumar, Kumari Asha, and Babu Raman Ram. "A Cross Sectional Observational Assessment of the Prescription Pattern in Ischemic Heart Disease." International Journal of Toxicological and Pharmacological Research 13, no. 6 (2023): 168–73. https://doi.org/10.5281/zenodo.11160988.

Full text
Abstract:
<strong>Aim:&nbsp;</strong>The aim of the present study was to analyze the drug prescribing pattern for treatment of ischemic heart disease.&nbsp;<strong>Methods:&nbsp;</strong>This was a cross sectional observational study conducted on ischemic heart disease patients admitted at inpatient department of Medicine in Darbhanga Medical College and Hospital, Laheriasarai, Darbhanga, Bihar, India for 18 months. The study consisted of analysis of drug utilization pattern of prescribed drugs. A total number of 200 patients were enrolled in the study.&nbsp;<strong>Results:&nbsp;</strong>IHD was more c
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Anti-anginal/anti ischemic"

1

AlJaroudi, Wael. Risk Assessment in Acute Coronary Syndromes. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199392094.003.0013.

Full text
Abstract:
Acute coronary syndromes (ACS) include unstable angina pectoris (UAP), non-ST elevation (NSTEMI), and ST elevation acute myocardial infarction (STEMI). Each year, more than 2 million people are hospitalized with ACS in the United States. The initial treatment has evolved over the last few decades from conservative management to early reperfusion therapy. Medical therapy has also significantly changed with the use of newer more potent antiplatelet agents, beta-blockers, angiotensin converting enzyme inhibitors, statins, and anti-anginal drugs, which have resulted in improvement of patient care
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Anti-anginal/anti ischemic"

1

McCann, Hugh A., and John Ross. "Combination Anti-Anginal Therapy: Rationale and Results." In Pathophysiology and Rational Pharmacotherapy of Myocardial Ischemia. Steinkopff, 1990. http://dx.doi.org/10.1007/978-3-642-54133-9_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Anti-anginal/anti ischemic' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography